Development of Magnetic Resonance (MR) Simulation for Treatment Planning
Completed
- Conditions
- First Posted Date
- 2006-04-14
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 10
- Registration Number
- NCT00314496
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer
Not Applicable
Completed
- Conditions
- First Posted Date
- 2006-04-04
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 16
- Registration Number
- NCT00310479
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Pulse Sequence Development on 3T Magnetic Resonance Imaging/Spectroscopy
Completed
- Conditions
- First Posted Date
- 2006-04-03
- Last Posted Date
- 2016-02-26
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 40
- Registration Number
- NCT00309504
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast Carcinoma
Phase 2
Terminated
- Conditions
- First Posted Date
- 2006-02-14
- Last Posted Date
- 2024-06-14
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 72
- Registration Number
- NCT00291304
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer
Phase 2
Completed
- Conditions
- First Posted Date
- 2006-01-04
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 30
- Registration Number
- NCT00271687
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea
- First Posted Date
- 2005-11-18
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 130
- Registration Number
- NCT00255229
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide
Phase 1
Completed
- Conditions
- First Posted Date
- 2005-11-08
- Last Posted Date
- 2016-02-24
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 26
- Registration Number
- NCT00250211
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Trial of Combined Aerobic and Resistance Exercise in Breast Cancer Survivors
- First Posted Date
- 2005-11-07
- Last Posted Date
- 2016-07-18
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 301
- Registration Number
- NCT00249015
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
MVCT Imaging Pilot Study Using Helical Tomotherapy
Completed
- Conditions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2016-02-24
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 16
- Registration Number
- NCT00168142
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2016-02-24
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 42
- Registration Number
- NCT00168116
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Β© Copyright 2024. All Rights Reserved by MedPath